Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Fyza Y. Shaikh"'
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 642-647 (2019)
The microbiome is increasingly recognized for its role in multiple aspects of cancer development and treatment, specifically in response to checkpoint inhibitors. While checkpoint inhibitors have revolutionized cancer treatment by producing durable a
Externí odkaz:
https://doaj.org/article/db4d340f5ea34381a02bf8f5cfac0e36
Autor:
Fyza Y. Shaikh, Reagan G. Cox, Aaron W. Lifland, Anne L. Hotard, John V. Williams, Martin L. Moore, Philip J. Santangelo, James E. Crowe
Publikováno v:
mBio, Vol 3, Iss 1 (2012)
ABSTRACT Respiratory syncytial virus (RSV) is a single-stranded RNA virus in the Paramyxoviridae family that assembles into filamentous structures at the apical surface of polarized epithelial cells. These filaments contain viral genomic RNA and stru
Externí odkaz:
https://doaj.org/article/415b299e036d4dc4b9541181cd84fc96
Autor:
Pakhi Birla, Fyza Y. Shaikh
Publikováno v:
Cancer and Metastasis Reviews. 41:335-346
Autor:
Fyza Y. Shaikh, Joell J. Gills, Fuad Mohammad, James R. White, Courtney M. Stevens, Hua Ding, Juan Fu, Ada Tam, Richard L. Blosser, Jada C. Domingue, Tatianna C. Larman, Jamie E. Chaft, Jonathan D. Spicer, Joshua E. Reuss, Jarushka Naidoo, Patrick M. Forde, Sudipto Ganguly, Franck Housseau, Drew M. Pardoll, Cynthia L. Sears
Publikováno v:
Cancer Immunol Immunother
Human gut microbial species found to associate with clinical responses to immune checkpoint inhibitors (ICIs) are often tested in mice using fecal microbiota transfer (FMT), wherein tumor responses in recipient mice may recapitulate human responses t
Autor:
Cynthia L. Sears, Drew M. Pardoll, Jarushka Naidoo, Evan J. Lipson, Jiyoung Ahn, Jeffrey S. Weber, Abhishek Pandey, Mykhaylo Usyk, Yusuke Okuma, Bertrand Routy, Corentin Richard, Taiki Hakozaki, Joell J. Gills, James R. White, Fyza Y. Shaikh
Figure S4: Sensitivity and specificity analysis of the Integrated Microbiome Prediction Index for response prediction in responder (R) vs nonresponder (NR), further stratified by inclusion (+) or exclusion (-) of stable disease (SD) if available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fe93ed658c5549b51ebf42a400d66f
https://doi.org/10.1158/1078-0432.22482081.v1
https://doi.org/10.1158/1078-0432.22482081.v1
Autor:
Cynthia L. Sears, Drew M. Pardoll, Jarushka Naidoo, Evan J. Lipson, Jiyoung Ahn, Jeffrey S. Weber, Abhishek Pandey, Mykhaylo Usyk, Yusuke Okuma, Bertrand Routy, Corentin Richard, Taiki Hakozaki, Joell J. Gills, James R. White, Fyza Y. Shaikh
Table S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb797c4c473ebe70013e13c7e000cbd8
https://doi.org/10.1158/1078-0432.22482060
https://doi.org/10.1158/1078-0432.22482060
Autor:
Cynthia L. Sears, Drew M. Pardoll, Jarushka Naidoo, Evan J. Lipson, Jiyoung Ahn, Jeffrey S. Weber, Abhishek Pandey, Mykhaylo Usyk, Yusuke Okuma, Bertrand Routy, Corentin Richard, Taiki Hakozaki, Joell J. Gills, James R. White, Fyza Y. Shaikh
Supplemental figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032db3a2e352ae4d2a6d44efa1d7ca04
https://doi.org/10.1158/1078-0432.22482069.v1
https://doi.org/10.1158/1078-0432.22482069.v1
Autor:
Cynthia L. Sears, Drew M. Pardoll, Jarushka Naidoo, Evan J. Lipson, Jiyoung Ahn, Jeffrey S. Weber, Abhishek Pandey, Mykhaylo Usyk, Yusuke Okuma, Bertrand Routy, Corentin Richard, Taiki Hakozaki, Joell J. Gills, James R. White, Fyza Y. Shaikh
Purpose:While immune checkpoint inhibitors (ICI) have revolutionized the treatment of cancer by producing durable antitumor responses, only 10%–30% of treated patients respond and the ability to predict clinical benefit remains elusive. Several stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183392685ef81f4722539017dda53a9a
https://doi.org/10.1158/1078-0432.c.6530814
https://doi.org/10.1158/1078-0432.c.6530814
Autor:
Blair V. Landon, Ronan J. Kelly, Ali H. Zaidi, Archana Balan, Jenna V. Canzoniero, Gavin Pereira, Zineb Belcaid, Russell K. Hales, K Ranh Voong, Richard J. Battafarano, Blair A. Jobe, Stephen C. Yang, Stephen Broderick, Jinny Ha, Kellie N. Smith, Elizabeth Thompson, Fyza Y. Shaikh, James R. White, Cynthia L. Sears, Eun J. Shin, Ali I. Amjad, Benny Weksler, Josephine L. Feliciano, Chen Hu, Vincent K. Lam, Valsamo Anagnostou
Publikováno v:
Cancer Research. 83:3374-3374
Introduction: There is a critical need to incorporate molecular assessments of minimal residual disease (MRD) during neoadjuvant immunotherapy, in order to identify individuals at high risk for disease recurrence based on analyses of circulating cell
Autor:
Mykhaylo Usyk, Bertrand Routy, Yusuke Okuma, Jiyoung Ahn, Jeffrey S. Weber, Taiki Hakozaki, Evan J. Lipson, Corentin Richard, Jarushka Naidoo, Abhishek Pandey, James R. White, Joell J. Gills, Drew M. Pardoll, Fyza Y. Shaikh, Cynthia L. Sears
Publikováno v:
Clin Cancer Res
Purpose: While immune checkpoint inhibitors (ICI) have revolutionized the treatment of cancer by producing durable antitumor responses, only 10%–30% of treated patients respond and the ability to predict clinical benefit remains elusive. Several st